Antiviral effect of cetylpyridinium chloride in mouthwash on SARS-CoV-2
Cetylpyridinium chloride (CPC), a quaternary ammonium compound, which is present in mouthwash, is effective against bacteria, fungi, and enveloped viruses. This study was conducted to explore the antiviral effect of CPC on SARS-CoV-2. There are few reports on the effect of CPC against wild-type SARS...
Saved in:
| Published in | Scientific reports Vol. 12; no. 1; pp. 14050 - 8 |
|---|---|
| Main Authors | , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
18.08.2022
Nature Publishing Group Nature Portfolio |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Cetylpyridinium chloride (CPC), a quaternary ammonium compound, which is present in mouthwash, is effective against bacteria, fungi, and enveloped viruses. This study was conducted to explore the antiviral effect of CPC on SARS-CoV-2. There are few reports on the effect of CPC against wild-type SARS-CoV-2 at low concentrations such as 0.001%–0.005% (10–50 µg/mL). Interestingly, we found that low concentrations of CPC suppressed the infectivity of human isolated SARS-CoV-2 strains (Wuhan, Alpha, Beta, and Gamma) even in saliva. Furthermore, we demonstrated that CPC shows anti-SARS-CoV-2 effects without disrupting the virus envelope, using sucrose density analysis and electron microscopic examination. In conclusion, this study provided experimental evidence that CPC may inhibit SARS-CoV-2 infection even at lower concentrations. |
|---|---|
| AbstractList | Cetylpyridinium chloride (CPC), a quaternary ammonium compound, which is present in mouthwash, is effective against bacteria, fungi, and enveloped viruses. This study was conducted to explore the antiviral effect of CPC on SARS-CoV-2. There are few reports on the effect of CPC against wild-type SARS-CoV-2 at low concentrations such as 0.001%-0.005% (10-50 µg/mL). Interestingly, we found that low concentrations of CPC suppressed the infectivity of human isolated SARS-CoV-2 strains (Wuhan, Alpha, Beta, and Gamma) even in saliva. Furthermore, we demonstrated that CPC shows anti-SARS-CoV-2 effects without disrupting the virus envelope, using sucrose density analysis and electron microscopic examination. In conclusion, this study provided experimental evidence that CPC may inhibit SARS-CoV-2 infection even at lower concentrations.Cetylpyridinium chloride (CPC), a quaternary ammonium compound, which is present in mouthwash, is effective against bacteria, fungi, and enveloped viruses. This study was conducted to explore the antiviral effect of CPC on SARS-CoV-2. There are few reports on the effect of CPC against wild-type SARS-CoV-2 at low concentrations such as 0.001%-0.005% (10-50 µg/mL). Interestingly, we found that low concentrations of CPC suppressed the infectivity of human isolated SARS-CoV-2 strains (Wuhan, Alpha, Beta, and Gamma) even in saliva. Furthermore, we demonstrated that CPC shows anti-SARS-CoV-2 effects without disrupting the virus envelope, using sucrose density analysis and electron microscopic examination. In conclusion, this study provided experimental evidence that CPC may inhibit SARS-CoV-2 infection even at lower concentrations. Cetylpyridinium chloride (CPC), a quaternary ammonium compound, which is present in mouthwash, is effective against bacteria, fungi, and enveloped viruses. This study was conducted to explore the antiviral effect of CPC on SARS-CoV-2. There are few reports on the effect of CPC against wild-type SARS-CoV-2 at low concentrations such as 0.001%–0.005% (10–50 µg/mL). Interestingly, we found that low concentrations of CPC suppressed the infectivity of human isolated SARS-CoV-2 strains (Wuhan, Alpha, Beta, and Gamma) even in saliva. Furthermore, we demonstrated that CPC shows anti-SARS-CoV-2 effects without disrupting the virus envelope, using sucrose density analysis and electron microscopic examination. In conclusion, this study provided experimental evidence that CPC may inhibit SARS-CoV-2 infection even at lower concentrations. Cetylpyridinium chloride (CPC), a quaternary ammonium compound, which is present in mouthwash, is effective against bacteria, fungi, and enveloped viruses. This study was conducted to explore the antiviral effect of CPC on SARS-CoV-2. There are few reports on the effect of CPC against wild-type SARS-CoV-2 at low concentrations such as 0.001%–0.005% (10–50 µg/mL). Interestingly, we found that low concentrations of CPC suppressed the infectivity of human isolated SARS-CoV-2 strains (Wuhan, Alpha, Beta, and Gamma) even in saliva. Furthermore, we demonstrated that CPC shows anti-SARS-CoV-2 effects without disrupting the virus envelope, using sucrose density analysis and electron microscopic examination. In conclusion, this study provided experimental evidence that CPC may inhibit SARS-CoV-2 infection even at lower concentrations. Abstract Cetylpyridinium chloride (CPC), a quaternary ammonium compound, which is present in mouthwash, is effective against bacteria, fungi, and enveloped viruses. This study was conducted to explore the antiviral effect of CPC on SARS-CoV-2. There are few reports on the effect of CPC against wild-type SARS-CoV-2 at low concentrations such as 0.001%–0.005% (10–50 µg/mL). Interestingly, we found that low concentrations of CPC suppressed the infectivity of human isolated SARS-CoV-2 strains (Wuhan, Alpha, Beta, and Gamma) even in saliva. Furthermore, we demonstrated that CPC shows anti-SARS-CoV-2 effects without disrupting the virus envelope, using sucrose density analysis and electron microscopic examination. In conclusion, this study provided experimental evidence that CPC may inhibit SARS-CoV-2 infection even at lower concentrations. |
| ArticleNumber | 14050 |
| Author | Takeda, Ryo Tsumita, Takuya Hida, Yasuhiro Maishi, Nako Hida, Kyoko Orba, Yasuko Sawa, Hirofumi Sano, Hidehiko Kitagawa, Yoshimasa Ushijima, Natsumi Sasaki, Michihito |
| Author_xml | – sequence: 1 givenname: Ryo surname: Takeda fullname: Takeda, Ryo organization: Vascular Biology and Molecular Pathology, Faculty of Dental Medicine and Graduate School of Dental Medicine, Hokkaido University, Oral Diagnosis and Medicine, Faculty of Dental Medicine and Graduate School of Dental Medicine, Hokkaido University – sequence: 2 givenname: Hirofumi surname: Sawa fullname: Sawa, Hirofumi organization: Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, One Health Research Center, Hokkaido University – sequence: 3 givenname: Michihito surname: Sasaki fullname: Sasaki, Michihito organization: Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University – sequence: 4 givenname: Yasuko surname: Orba fullname: Orba, Yasuko organization: Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University – sequence: 5 givenname: Nako surname: Maishi fullname: Maishi, Nako organization: Vascular Biology and Molecular Pathology, Faculty of Dental Medicine and Graduate School of Dental Medicine, Hokkaido University – sequence: 6 givenname: Takuya surname: Tsumita fullname: Tsumita, Takuya organization: Vascular Biology and Molecular Pathology, Faculty of Dental Medicine and Graduate School of Dental Medicine, Hokkaido University – sequence: 7 givenname: Natsumi surname: Ushijima fullname: Ushijima, Natsumi organization: Support Section for Education and Research, Graduate School of Dental Medicine, Hokkaido University – sequence: 8 givenname: Yasuhiro surname: Hida fullname: Hida, Yasuhiro organization: Community Service and Welfare Network, Hokkaido University Hospital – sequence: 9 givenname: Hidehiko surname: Sano fullname: Sano, Hidehiko organization: Restorative Dentistry, Faculty of Dental Medicine and Graduate School of Dental Medicine, Hokkaido University – sequence: 10 givenname: Yoshimasa surname: Kitagawa fullname: Kitagawa, Yoshimasa organization: Oral Diagnosis and Medicine, Faculty of Dental Medicine and Graduate School of Dental Medicine, Hokkaido University – sequence: 11 givenname: Kyoko surname: Hida fullname: Hida, Kyoko email: khida@den.hokudai.ac.jp organization: Vascular Biology and Molecular Pathology, Faculty of Dental Medicine and Graduate School of Dental Medicine, Hokkaido University |
| BookMark | eNp9kU9vFCEYxompsbX2C3iaxIuXUf4NAxeTzabWJk1MrHolzDuwy2YGVpip2W8v26nR9lAu8MLz_ID3eY1OQgwWobcEfyCYyY-Zk0bJGlNaE8lEW4sX6Ixi3tSUUXry3_oUXeS8w2U0VHGiXqFTVqyUEHmGrlZh8nc-maGyzlmYqugqsNNh2B-S733w81jBdoilsJUP1Rjnafvb5G0VQ3W7-nZbr-PPmr5BL50Zsr14mM_Rj8-X39df6puvV9fr1U0NgrZTDU0rle2ASdsZ6IVpHJZO0AZcg3srgBrWdx3ue-Ogk8q12LKecgCJiXIdO0fXC7ePZqf3yY8mHXQ0Xt9vxLTRJk0eBqsN4bwTHdCC5pizrgAALEihKGatLaxPC2s_d6PtwYap9OER9PFJ8Fu9iXdaMSlESwrg_QMgxV-zzZMefQY7DCbYOGdNW8xl0WFVpO-eSHdxTqG06qhiQnHJWFHJRQUp5pys0-AnM_l4vN8PmmB9DF8v4esSvr4PX4tipU-sf__xrIktplzEYWPTv1c94_oDzpPCzQ |
| CitedBy_id | crossref_primary_10_1007_s12221_024_00729_8 crossref_primary_10_1021_acsomega_3c01110 crossref_primary_10_1186_s12903_024_04246_1 crossref_primary_10_3390_molecules29163802 crossref_primary_10_3390_life13122312 crossref_primary_10_1007_s00284_023_03198_z crossref_primary_10_1016_j_jebdp_2024_102040 crossref_primary_10_1016_j_molliq_2024_124300 crossref_primary_10_1016_j_scitotenv_2024_178020 crossref_primary_10_1186_s12903_023_03126_4 crossref_primary_10_3389_fmicb_2024_1392018 crossref_primary_10_2115_fiberst_2024_0007 crossref_primary_10_7717_peerj_15080 crossref_primary_10_22490_24629448_6590 crossref_primary_10_3390_app13127290 crossref_primary_10_1007_s00784_023_05034_x crossref_primary_10_1016_j_jdsr_2023_09_003 crossref_primary_10_1039_D3CB00166K crossref_primary_10_1128_spectrum_02712_23 crossref_primary_10_1099_acmi_0_000631_v5 crossref_primary_10_3390_v15071433 |
| Cites_doi | 10.1056/nejmoa2108891 10.1007/s40121-018-0200-7 10.1128/JVI.00023-19 10.1128/AAC.00576-20 10.3390/ijerph19052877 10.1038/s41591-020-1092-0 10.1053/j.gastro.2020.05.003 10.1080/20002297.2022.2030094 10.1099/jmm.0.001508 10.1177/00220345211029269 10.20411/pai.v2i2.200 10.1038/s41591-021-01296-8 10.1016/S0140-6736(20)31185-5 10.7326/M20-0504 10.1038/s41586-020-2196-x 10.1111/dth.14578 10.3390/covid1020037 10.1126/science.abd9149 10.3390/v13030384 10.1056/NEJMoa2001017 10.1038/s41379-020-0595-z 10.1056/NEJMoa2109072 10.1128/JVI.00957-20 10.1016/j.cyto.2005.07.002 10.1016/s0140-6736(21)02758-6 10.3390/healthcare10030469 10.1016/j.ejpb.2015.01.007 10.1007/s15010-020-01563-9 10.1183/13993003.01948-2020 10.3390/antibiotics10050550 10.1016/j.ajoms.2021.02.002 10.1371/journal.ppat.1009233 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2022 The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022. The Author(s). |
| Copyright_xml | – notice: The Author(s) 2022 – notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022. The Author(s). |
| DBID | C6C AAYXX CITATION 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU COVID DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
| DOI | 10.1038/s41598-022-18367-6 |
| DatabaseName | Springer Nature OA Free Journals CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Natural Science Collection ProQuest One Community College Coronavirus Research Database ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni) Proquest Medical Database ProQuest Science Database (NC LIVE) ProQuest Biological Science Database (NC LIVE) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database CrossRef |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology Medicine Dentistry |
| EISSN | 2045-2322 |
| EndPage | 8 |
| ExternalDocumentID | oai_doaj_org_article_a144b6bc2f504043b19fccec8692037e PMC9386671 10_1038_s41598_022_18367_6 |
| GrantInformation_xml | – fundername: Japan Agency for Medical Research and Development grantid: 20fk0108537h0001 funderid: http://dx.doi.org/10.13039/100009619 – fundername: ; grantid: 20fk0108537h0001 |
| GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFPKN CITATION PHGZM PHGZT 7XB 8FK AARCD COVID K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c627t-c5789ebc38ebacd6a5f08f625cf50de6c2a3dbb0ddafcb89f70e3d24cc8019fb3 |
| IEDL.DBID | 7X7 |
| ISSN | 2045-2322 |
| IngestDate | Wed Aug 27 01:30:45 EDT 2025 Thu Aug 21 14:09:02 EDT 2025 Thu Jul 10 19:23:59 EDT 2025 Wed Aug 13 05:29:17 EDT 2025 Tue Jul 01 04:17:06 EDT 2025 Thu Apr 24 23:11:51 EDT 2025 Fri Feb 21 02:40:12 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c627t-c5789ebc38ebacd6a5f08f625cf50de6c2a3dbb0ddafcb89f70e3d24cc8019fb3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://www.proquest.com/docview/2703694833?pq-origsite=%requestingapplication% |
| PMID | 35982118 |
| PQID | 2703694833 |
| PQPubID | 2041939 |
| PageCount | 8 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_a144b6bc2f504043b19fccec8692037e pubmedcentral_primary_oai_pubmedcentral_nih_gov_9386671 proquest_miscellaneous_2704871309 proquest_journals_2703694833 crossref_citationtrail_10_1038_s41598_022_18367_6 crossref_primary_10_1038_s41598_022_18367_6 springer_journals_10_1038_s41598_022_18367_6 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2022-08-18 |
| PublicationDateYYYYMMDD | 2022-08-18 |
| PublicationDate_xml | – month: 08 year: 2022 text: 2022-08-18 day: 18 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London |
| PublicationTitle | Scientific reports |
| PublicationTitleAbbrev | Sci Rep |
| PublicationYear | 2022 |
| Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
| References | Lopez BernalJEffectiveness of covid-19 vaccines against the B.1.617.2 (delta) variantN. Engl. J. Med.20213855855941:CAS:528:DC%2BB3MXhvVeqt7nJ10.1056/nejmoa210889134289274 AndersonERCPC-containing oral rinses inactivate SARS-CoV-2 variants and are active in the presence of human salivaJ. Med. Microbiol.202210.1099/jmm.0.001508351800468941951 ShenLHigh-throughput screening and identification of potent broad-spectrum inhibitors of coronavirusesJ. Virol.201993e000231:CAS:528:DC%2BC1MXhvVCqtbjM10.1128/JVI.00023-19309180746613765 PopkinDLCetylpyridinium chloride (CPC) exhibits potent, rapid activity against influenza viruses in vitro and in vivoPathog. Immun.2017225226910.20411/pai.v2i2.20028936484 KomineAYamaguchiEOkamotoNYamamotoKVirucidal activity of oral care products against SARS-CoV-2 in vitroJ. Oral Maxillofac. Surg. Med. Pathol.20213347547710.1016/j.ajoms.2021.02.002336438367898974 SchaeferI-MIn situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19Mod. Pathol.202033210421141:CAS:528:DC%2BB3cXht1alurnL10.1038/s41379-020-0595-z325618497304376 Tracking SARS-CoV-2 variants. (2022). https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/. AzizMTaste changes (dysgeusia) in COVID-19: A systematic review and meta-analysisGastroenterology2020159113211331:CAS:528:DC%2BB3cXhs1aqurbL10.1053/j.gastro.2020.05.00332387496 KishimotoMTMPRSS11D and TMPRSS13 activate the SARS-CoV-2 spike proteinViruses2021133841:CAS:528:DC%2BB3MXpvF2qsLY%3D10.3390/v13030384 ChenMElevated ACE-2 expression in the olfactory neuroepithelium: Implications for anosmia and upper respiratory SARS-CoV-2 entry and replicationEur. Respir. J.20205620019481:CAS:528:DC%2BB3cXitVKrtbfJ10.1183/13993003.01948-2020328170047439429 GittingsSTurnbullNHenryBRobertsCJGershkovichPCharacterisation of human saliva as a platform for oral dissolution medium developmentEur. J. Pharm. Biopharm.20159116241:CAS:528:DC%2BC2MXhsFSisb0%3D10.1016/j.ejpb.2015.01.00725603197 AdamDCClustering and superspreading potential of SARS-CoV-2 infections in Hong KongNat. Med.202026171417191:CAS:528:DC%2BB3cXhvVGhtL3F10.1038/s41591-020-1092-032943787 Muñoz-BasagoitiJMouthwashes with CPC reduce the infectivity of SARS-CoV-2 variants in vitroJ. Dent. Res.2021100126512721:CAS:528:DC%2BB3MXitFSgurvN10.1177/0022034521102926934282982 OverberghLValidation of real-time RT-PCR assays for mRNA quantification in baboonsCytokine2005314544581:CAS:528:DC%2BD2MXpvV2mur8%3D10.1016/j.cyto.2005.07.00216129617 SasakiMSARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cellsPLOS Pathog.2021171:CAS:528:DC%2BB3MXjtlOhtr4%3D10.1371/journal.ppat.1009233334763277853460 Bañó-PoloMCetylpyridinium chloride promotes disaggregation of SARS-CoV-2 virus-like particlesJ. Oral Microbiol.20221420300941:CAS:528:DC%2BB38XhvVOrsb8%3D10.1080/20002297.2022.2030094350876418788378 WölfelRVirological assessment of hospitalized patients with COVID-2019Nature20205814654692020Natur.581..465W1:CAS:528:DC%2BB3cXpvVantb8%3D10.1038/s41586-020-2196-x32235945 KarimSSAKarimQAOmicron SARS-CoV-2 variant: A new chapter in the COVID-19 pandemicLancet2021398212621281:CAS:528:DC%2BB3MXis1yhsrfN10.1016/s0140-6736(21)02758-6348715458640673 IranmaneshBKhaliliMAmiriRZartabHAflatoonianMOral manifestations of COVID-19 disease: A review articleDermatol. Ther.2021341:CAS:528:DC%2BB3MXps1Cmt78%3D10.1111/dth.1457833236823 MaoXCetylpyridinium chloride: Mechanism of action, antimicrobial efficacy in biofilms, and potential risks of resistanceAntimicrob. Agents Chemother.202064e005761:CAS:528:DC%2BB3cXhslCju7nN10.1128/AAC.00576-20325137927526810 Wang ChiaCAirborne transmission of respiratory virusesScience202137391491:CAS:528:DC%2BB3MXhvFWis7nJ10.1126/science.abd9149 SteyerAMarušićMKolencMTriglavTA throat lozenge with fixed combination of cetylpyridinium chloride and benzydamine hydrochloride has direct virucidal effect on SARS-CoV-2COVID202110.3390/covid1020037 VargaZElectron microscopy of SARS-CoV-2: A challenging task: Authors' replyLancet20203951:CAS:528:DC%2BB3cXpvFagt7g%3D10.1016/S0140-6736(20)31185-5324425277237177 Garcia-SanchezAVirucidal activity of different mouthwashes against the salivary load of SARS-CoV-2: A narrative reviewHealthcare20221046910.3390/healthcare10030469 BuonavogliaAAntibiotics or no antibiotics, that is the question: An update on efficient and effective use of antibiotics in dental practiceAntibiotics2021105501:CAS:528:DC%2BB3MXitVCjtLvP10.3390/antibiotics10050550 SeneviratneCJEfficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: Randomized control trial in SingaporeInfection2021493053111:CAS:528:DC%2BB3MXitVyltw%3D%3D10.1007/s15010-020-01563-933315181 ZhuNA novel coronavirus from patients with pneumonia in China, 2019N. Engl. J. Med.20203827277331:CAS:528:DC%2BB3cXjslGmsrc%3D10.1056/NEJMoa2001017319789457092803 COVID-19 Dashboard. (2022). https://coronavirus.jhu.edu/map.html. MilewskaAReplication of severe acute respiratory syndrome coronavirus 2 in human respiratory epitheliumJ. Virol.202094e00920e0095710.1128/JVI.00957-20 HuangNSARS-CoV-2 infection of the oral cavity and salivaNat. Med.2021278929031:CAS:528:DC%2BB3MXnsFKjs7o%3D10.1038/s41591-021-01296-8337674058240394 EggersMKoburger-JanssenTEickmannMZornJIn vitro bactericidal and virucidal efficacy of povidone-iodine gargle/mouthwash against respiratory and oral tract pathogensInfect. Dis. Ther.2018724925910.1007/s40121-018-0200-7296331775986684 Garcia-SanchezAPovidone-iodine as a pre-procedural mouthwash to reduce the salivary viral load of SARS-CoV-2: A systematic review of randomized controlled trialsInt. J. Environ. Res. Public Health20221928771:CAS:528:DC%2BB38Xnt1SgtLs%3D10.3390/ijerph19052877 LauerSAThe incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and applicationAnn. Intern. Med.202017257758210.7326/M20-050432150748 BergwerkMCovid-19 breakthrough infections in vaccinated health care workersN. Engl. J. Med.2021385147414841:CAS:528:DC%2BB3MXit1Crt7jN10.1056/NEJMoa210907234320281 18367_CR1 L Overbergh (18367_CR33) 2005; 31 M Kishimoto (18367_CR34) 2021; 13 18367_CR3 A Buonavoglia (18367_CR21) 2021; 10 ER Anderson (18367_CR26) 2022 X Mao (18367_CR29) 2020; 64 A Steyer (18367_CR28) 2021 A Milewska (18367_CR10) 2020; 94 C Wang Chia (18367_CR13) 2021; 373 DL Popkin (18367_CR19) 2017; 2 M Bergwerk (18367_CR4) 2021; 385 B Iranmanesh (18367_CR9) 2021; 34 CJ Seneviratne (18367_CR23) 2021; 49 A Garcia-Sanchez (18367_CR18) 2022; 10 J Muñoz-Basagoiti (18367_CR24) 2021; 100 Z Varga (18367_CR30) 2020; 395 M Chen (18367_CR31) 2020; 56 I-M Schaefer (18367_CR11) 2020; 33 A Komine (18367_CR25) 2021; 33 M Bañó-Polo (18367_CR22) 2022; 14 J Lopez Bernal (18367_CR6) 2021; 385 N Huang (18367_CR7) 2021; 27 A Garcia-Sanchez (18367_CR17) 2022; 19 N Zhu (18367_CR2) 2020; 382 R Wölfel (18367_CR15) 2020; 581 M Eggers (18367_CR16) 2018; 7 L Shen (18367_CR20) 2019; 93 M Sasaki (18367_CR32) 2021; 17 M Aziz (18367_CR8) 2020; 159 DC Adam (18367_CR12) 2020; 26 S Gittings (18367_CR27) 2015; 91 SA Lauer (18367_CR14) 2020; 172 SSA Karim (18367_CR5) 2021; 398 |
| References_xml | – reference: Muñoz-BasagoitiJMouthwashes with CPC reduce the infectivity of SARS-CoV-2 variants in vitroJ. Dent. Res.2021100126512721:CAS:528:DC%2BB3MXitFSgurvN10.1177/0022034521102926934282982 – reference: KomineAYamaguchiEOkamotoNYamamotoKVirucidal activity of oral care products against SARS-CoV-2 in vitroJ. Oral Maxillofac. Surg. Med. Pathol.20213347547710.1016/j.ajoms.2021.02.002336438367898974 – reference: Bañó-PoloMCetylpyridinium chloride promotes disaggregation of SARS-CoV-2 virus-like particlesJ. Oral Microbiol.20221420300941:CAS:528:DC%2BB38XhvVOrsb8%3D10.1080/20002297.2022.2030094350876418788378 – reference: SchaeferI-MIn situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19Mod. Pathol.202033210421141:CAS:528:DC%2BB3cXht1alurnL10.1038/s41379-020-0595-z325618497304376 – reference: ChenMElevated ACE-2 expression in the olfactory neuroepithelium: Implications for anosmia and upper respiratory SARS-CoV-2 entry and replicationEur. Respir. J.20205620019481:CAS:528:DC%2BB3cXitVKrtbfJ10.1183/13993003.01948-2020328170047439429 – reference: EggersMKoburger-JanssenTEickmannMZornJIn vitro bactericidal and virucidal efficacy of povidone-iodine gargle/mouthwash against respiratory and oral tract pathogensInfect. Dis. Ther.2018724925910.1007/s40121-018-0200-7296331775986684 – reference: COVID-19 Dashboard. (2022). https://coronavirus.jhu.edu/map.html. – reference: WölfelRVirological assessment of hospitalized patients with COVID-2019Nature20205814654692020Natur.581..465W1:CAS:528:DC%2BB3cXpvVantb8%3D10.1038/s41586-020-2196-x32235945 – reference: Garcia-SanchezAPovidone-iodine as a pre-procedural mouthwash to reduce the salivary viral load of SARS-CoV-2: A systematic review of randomized controlled trialsInt. J. Environ. Res. Public Health20221928771:CAS:528:DC%2BB38Xnt1SgtLs%3D10.3390/ijerph19052877 – reference: AzizMTaste changes (dysgeusia) in COVID-19: A systematic review and meta-analysisGastroenterology2020159113211331:CAS:528:DC%2BB3cXhs1aqurbL10.1053/j.gastro.2020.05.00332387496 – reference: Tracking SARS-CoV-2 variants. (2022). https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/. – reference: BergwerkMCovid-19 breakthrough infections in vaccinated health care workersN. Engl. J. Med.2021385147414841:CAS:528:DC%2BB3MXit1Crt7jN10.1056/NEJMoa210907234320281 – reference: SteyerAMarušićMKolencMTriglavTA throat lozenge with fixed combination of cetylpyridinium chloride and benzydamine hydrochloride has direct virucidal effect on SARS-CoV-2COVID202110.3390/covid1020037 – reference: LauerSAThe incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and applicationAnn. Intern. Med.202017257758210.7326/M20-050432150748 – reference: AdamDCClustering and superspreading potential of SARS-CoV-2 infections in Hong KongNat. Med.202026171417191:CAS:528:DC%2BB3cXhvVGhtL3F10.1038/s41591-020-1092-032943787 – reference: SeneviratneCJEfficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: Randomized control trial in SingaporeInfection2021493053111:CAS:528:DC%2BB3MXitVyltw%3D%3D10.1007/s15010-020-01563-933315181 – reference: KarimSSAKarimQAOmicron SARS-CoV-2 variant: A new chapter in the COVID-19 pandemicLancet2021398212621281:CAS:528:DC%2BB3MXis1yhsrfN10.1016/s0140-6736(21)02758-6348715458640673 – reference: AndersonERCPC-containing oral rinses inactivate SARS-CoV-2 variants and are active in the presence of human salivaJ. Med. Microbiol.202210.1099/jmm.0.001508351800468941951 – reference: PopkinDLCetylpyridinium chloride (CPC) exhibits potent, rapid activity against influenza viruses in vitro and in vivoPathog. Immun.2017225226910.20411/pai.v2i2.20028936484 – reference: OverberghLValidation of real-time RT-PCR assays for mRNA quantification in baboonsCytokine2005314544581:CAS:528:DC%2BD2MXpvV2mur8%3D10.1016/j.cyto.2005.07.00216129617 – reference: ShenLHigh-throughput screening and identification of potent broad-spectrum inhibitors of coronavirusesJ. Virol.201993e000231:CAS:528:DC%2BC1MXhvVCqtbjM10.1128/JVI.00023-19309180746613765 – reference: Garcia-SanchezAVirucidal activity of different mouthwashes against the salivary load of SARS-CoV-2: A narrative reviewHealthcare20221046910.3390/healthcare10030469 – reference: IranmaneshBKhaliliMAmiriRZartabHAflatoonianMOral manifestations of COVID-19 disease: A review articleDermatol. Ther.2021341:CAS:528:DC%2BB3MXps1Cmt78%3D10.1111/dth.1457833236823 – reference: MilewskaAReplication of severe acute respiratory syndrome coronavirus 2 in human respiratory epitheliumJ. Virol.202094e00920e0095710.1128/JVI.00957-20 – reference: BuonavogliaAAntibiotics or no antibiotics, that is the question: An update on efficient and effective use of antibiotics in dental practiceAntibiotics2021105501:CAS:528:DC%2BB3MXitVCjtLvP10.3390/antibiotics10050550 – reference: SasakiMSARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cellsPLOS Pathog.2021171:CAS:528:DC%2BB3MXjtlOhtr4%3D10.1371/journal.ppat.1009233334763277853460 – reference: Lopez BernalJEffectiveness of covid-19 vaccines against the B.1.617.2 (delta) variantN. Engl. J. Med.20213855855941:CAS:528:DC%2BB3MXhvVeqt7nJ10.1056/nejmoa210889134289274 – reference: MaoXCetylpyridinium chloride: Mechanism of action, antimicrobial efficacy in biofilms, and potential risks of resistanceAntimicrob. Agents Chemother.202064e005761:CAS:528:DC%2BB3cXhslCju7nN10.1128/AAC.00576-20325137927526810 – reference: HuangNSARS-CoV-2 infection of the oral cavity and salivaNat. Med.2021278929031:CAS:528:DC%2BB3MXnsFKjs7o%3D10.1038/s41591-021-01296-8337674058240394 – reference: ZhuNA novel coronavirus from patients with pneumonia in China, 2019N. Engl. J. Med.20203827277331:CAS:528:DC%2BB3cXjslGmsrc%3D10.1056/NEJMoa2001017319789457092803 – reference: VargaZElectron microscopy of SARS-CoV-2: A challenging task: Authors' replyLancet20203951:CAS:528:DC%2BB3cXpvFagt7g%3D10.1016/S0140-6736(20)31185-5324425277237177 – reference: KishimotoMTMPRSS11D and TMPRSS13 activate the SARS-CoV-2 spike proteinViruses2021133841:CAS:528:DC%2BB3MXpvF2qsLY%3D10.3390/v13030384 – reference: GittingsSTurnbullNHenryBRobertsCJGershkovichPCharacterisation of human saliva as a platform for oral dissolution medium developmentEur. J. Pharm. Biopharm.20159116241:CAS:528:DC%2BC2MXhsFSisb0%3D10.1016/j.ejpb.2015.01.00725603197 – reference: Wang ChiaCAirborne transmission of respiratory virusesScience202137391491:CAS:528:DC%2BB3MXhvFWis7nJ10.1126/science.abd9149 – volume: 385 start-page: 585 year: 2021 ident: 18367_CR6 publication-title: N. Engl. J. Med. doi: 10.1056/nejmoa2108891 – volume: 7 start-page: 249 year: 2018 ident: 18367_CR16 publication-title: Infect. Dis. Ther. doi: 10.1007/s40121-018-0200-7 – volume: 93 start-page: e00023 year: 2019 ident: 18367_CR20 publication-title: J. Virol. doi: 10.1128/JVI.00023-19 – volume: 64 start-page: e00576 year: 2020 ident: 18367_CR29 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.00576-20 – volume: 19 start-page: 2877 year: 2022 ident: 18367_CR17 publication-title: Int. J. Environ. Res. Public Health doi: 10.3390/ijerph19052877 – volume: 26 start-page: 1714 year: 2020 ident: 18367_CR12 publication-title: Nat. Med. doi: 10.1038/s41591-020-1092-0 – volume: 159 start-page: 1132 year: 2020 ident: 18367_CR8 publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.05.003 – volume: 14 start-page: 2030094 year: 2022 ident: 18367_CR22 publication-title: J. Oral Microbiol. doi: 10.1080/20002297.2022.2030094 – year: 2022 ident: 18367_CR26 publication-title: J. Med. Microbiol. doi: 10.1099/jmm.0.001508 – volume: 100 start-page: 1265 year: 2021 ident: 18367_CR24 publication-title: J. Dent. Res. doi: 10.1177/00220345211029269 – volume: 2 start-page: 252 year: 2017 ident: 18367_CR19 publication-title: Pathog. Immun. doi: 10.20411/pai.v2i2.200 – volume: 27 start-page: 892 year: 2021 ident: 18367_CR7 publication-title: Nat. Med. doi: 10.1038/s41591-021-01296-8 – volume: 395 year: 2020 ident: 18367_CR30 publication-title: Lancet doi: 10.1016/S0140-6736(20)31185-5 – volume: 172 start-page: 577 year: 2020 ident: 18367_CR14 publication-title: Ann. Intern. Med. doi: 10.7326/M20-0504 – volume: 581 start-page: 465 year: 2020 ident: 18367_CR15 publication-title: Nature doi: 10.1038/s41586-020-2196-x – volume: 34 year: 2021 ident: 18367_CR9 publication-title: Dermatol. Ther. doi: 10.1111/dth.14578 – year: 2021 ident: 18367_CR28 publication-title: COVID doi: 10.3390/covid1020037 – volume: 373 start-page: 9149 year: 2021 ident: 18367_CR13 publication-title: Science doi: 10.1126/science.abd9149 – volume: 13 start-page: 384 year: 2021 ident: 18367_CR34 publication-title: Viruses doi: 10.3390/v13030384 – volume: 382 start-page: 727 year: 2020 ident: 18367_CR2 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2001017 – volume: 33 start-page: 2104 year: 2020 ident: 18367_CR11 publication-title: Mod. Pathol. doi: 10.1038/s41379-020-0595-z – volume: 385 start-page: 1474 year: 2021 ident: 18367_CR4 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2109072 – volume: 94 start-page: e00920 year: 2020 ident: 18367_CR10 publication-title: J. Virol. doi: 10.1128/JVI.00957-20 – volume: 31 start-page: 454 year: 2005 ident: 18367_CR33 publication-title: Cytokine doi: 10.1016/j.cyto.2005.07.002 – volume: 398 start-page: 2126 year: 2021 ident: 18367_CR5 publication-title: Lancet doi: 10.1016/s0140-6736(21)02758-6 – volume: 10 start-page: 469 year: 2022 ident: 18367_CR18 publication-title: Healthcare doi: 10.3390/healthcare10030469 – volume: 91 start-page: 16 year: 2015 ident: 18367_CR27 publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2015.01.007 – volume: 49 start-page: 305 year: 2021 ident: 18367_CR23 publication-title: Infection doi: 10.1007/s15010-020-01563-9 – ident: 18367_CR1 – volume: 56 start-page: 2001948 year: 2020 ident: 18367_CR31 publication-title: Eur. Respir. J. doi: 10.1183/13993003.01948-2020 – volume: 10 start-page: 550 year: 2021 ident: 18367_CR21 publication-title: Antibiotics doi: 10.3390/antibiotics10050550 – volume: 33 start-page: 475 year: 2021 ident: 18367_CR25 publication-title: J. Oral Maxillofac. Surg. Med. Pathol. doi: 10.1016/j.ajoms.2021.02.002 – ident: 18367_CR3 – volume: 17 year: 2021 ident: 18367_CR32 publication-title: PLOS Pathog. doi: 10.1371/journal.ppat.1009233 |
| SSID | ssj0000529419 |
| Score | 2.468081 |
| Snippet | Cetylpyridinium chloride (CPC), a quaternary ammonium compound, which is present in mouthwash, is effective against bacteria, fungi, and enveloped viruses.... Abstract Cetylpyridinium chloride (CPC), a quaternary ammonium compound, which is present in mouthwash, is effective against bacteria, fungi, and enveloped... |
| SourceID | doaj pubmedcentral proquest crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 14050 |
| SubjectTerms | 631/326/596 692/699/255 Ammonium Antiviral drugs Asymptomatic Cetylpyridinium chloride Chloride Coronaviruses COVID-19 Dentistry Disease transmission Drug dosages Humanities and Social Sciences Infections Infectivity Medicine Mouthwashes multidisciplinary Saliva Science Science (multidisciplinary) Severe acute respiratory syndrome coronavirus 2 Sucrose Transmission electron microscopy Viruses Zoonoses |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3daxQxEA9SEHwRtYpra0nBN12aTfby8XgtrUXQB2ulbyEfE-6g3S29O-T-eye7e9duQX3xdZPdbOYjM8NMfkPIB8GZCDk1CFWtyjpyXzpWQZkgKaGd1g7y3eGv3-T5Zf3lanL1oNVXrgnr4YF7wh059Pi99IGnCctIML4yKQQIWhpcRkE-fdHmPQimelRvburKDLdkmNBHC7RU-TYZxl4oxXg6yJEl6gD7R17m4xrJR4nSzv6cvSDPB8eRTvsffkmeQPOKPO1bSa53yedpk_tA4DdoX6JB20QDLNfXt-u7ORqo-eqGhlmut4tA5w29yb3zfrnFjLYNvZh-vyhP2p8lf00uz05_nJyXQ5OEMkiulmVAlTPgg9DgXYjSTRLTCaOagASLIAN3InrPYnQpeG2SYiAir0NA22SSF2_ITtM28JZQzpAzNaBZi1BrJrUy3ifFPVQ-IgMLUm0IZsOAIJ4bWVzbLpMttO2JbJHItiOylQX5uH3ntsfP-Ovs48yH7cyMfd09QImwg0TYf0lEQfY3XLSDQi4sz0BjptZCFORwO4yqlPMjroF21c3B8A2NuimIGnF_9EPjkWY-60C5jdBSqqognzZycr_4nzf87n9seI8841muM1Cv3ic7y7sVvEdXaekPOq34DfuzEDA priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB6VIh4XBAsVgYKMxA0CiZ21nQNCS6FUSMuBsqg3y092pW1S9iHYf884j0VblV4TO7HnoZnRzHwD8JLRjNmYGvR5IdLCUZPqLPdp8EEwqaXUPvYOj7_yk0nx5Wx4tgf9uKOOgMsrQ7s4T2qymL_582vzHhX-XdsyLt8u0QjFRjEMq1BAUfH5DbiJlklERR137n6L9U3LIi-73pmrt-7YpwbGf8f3vFw5eSl92lil4_twr3Mnyajl_wPY89UAbrUDJjcDuPMxFgPFeW4DuD3u0ugP4fOoikMj8NOkrecgdSDWrzbzi81ihtZstj4ndhqL85wns4qcx0F7v_VySuqKnI6-naZH9Y-UPoLJ8afvRydpN1EhtZyKVWpRP0tvLJPeaOu4HoZMBgyBbBhmznNLNXPGZM7pYI0sg8g8c7SwFg1ZGQw7gP2qrvxjIDRDNhYebaDzhcy4FKUxQVDjc-OQ2wnkPR2V7eDG49SLuWrS3kyqlvYKaa8a2iuewKvtnosWbOPa1R8ie7YrI1B286Be_FSd3imNAaPhxlK8YAQSMngNa72VvEQpFXjMw565qhc-RSMqWVlIxhJ4sX2NeheTKbry9bpZg7EeegBlAmJHKHYOtPummk0bBO-SSc5FnsDrXnz-_fz_F35y_Vmfwl0aBTni9cpD2F8t1v4Zekwr87xRg7-MbhID priority: 102 providerName: Scholars Portal – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZKERIX1PIQgVIZiRtEOHbWj-OyolSVyoFS1JvlJ7tSm1T7ENp_37GTLEoFSFwTO7HnkfFkZr5B6B2jhLkUGgxVLcraU1saUoUyhiiYNFKakGqHz7_y08v67GpytYfoUAuTk_YzpGX-TA_ZYR9XYGhSMRi4TiCEoNz8AXqYoNuTVM_4bPdfJUWu6kr19TGEyT9MHdmgDNU_Ol_ez468FyLNlufkAD3pj4x42i3yEO2F5il61DWR3D5DX6ZN6gABz8BdcgZuI3Zhvb2-3S4XYJoWmxvs5inTzge8aPBN6pr3y6zmuG3wxfTbRTlrf5T0Obo8-fx9dlr27RFKx6lYlw6UTQXrmAzWOM_NJBIZwZ9xcUJ84I4a5q0l3pvorFRRkMA8rZ0Dq6SiZS_QftM24SXClABP6gAGzYdaEi6FsjYKakNlPbCuQNVAMO167PDUwuJa5xg2k7ojsgYi60xkzQv0fjfntkPO-OfoT4kPu5EJ9TpfaJc_dS8F2oD3Z7l1FDaYUIEsbMO54CRXIHIClnk0cFH3qrjSNEGMqVoyVqC3u9ugRCkyYprQbvIYcNzAnKsCiRH3Rwsa32kW8wzHrZjkXFQF-jDIye-X_33Dr_5v-Gv0mCYJTmC88gjtr5eb8AaOQ2t7nOX_Dvb5BY0 priority: 102 providerName: Springer Nature |
| Title | Antiviral effect of cetylpyridinium chloride in mouthwash on SARS-CoV-2 |
| URI | https://link.springer.com/article/10.1038/s41598-022-18367-6 https://www.proquest.com/docview/2703694833 https://www.proquest.com/docview/2704871309 https://pubmed.ncbi.nlm.nih.gov/PMC9386671 https://doaj.org/article/a144b6bc2f504043b19fccec8692037e |
| Volume | 12 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgEx8vCAqIwKiCxBtES-zUdp5QVjamSp3QylDfIn9lrbQlpR9C_e-5S9xOmcReEil2Ett35_P5zr8j5DOjMTPoGnRJKqLUUh2pOHFR6UrBpJJSOTw7PL7g51fpaDqY-g23lQ-r3M2JzURta4N75McUkaKyVDL2bfEnwqxR6F31KTQek0OELsOQLjEV-z0W9GKlSebPysRMHq9AX-GZMrDAgJdhjuAdfdTA9nfWmvcjJe-5SxstdPaSvPDLxzBv6f2KPHJVjzxpE0pue-TZdwz-wfxtPfJ07N3mr8mPvMIkEfDpsI3fCOsyNG69vVlsl3PQXvPNbWhmGIxnXTivwltMrPdXrWZhXYWT_HISDevfEX1Drs5Ofw3PI59BITKcinVkQB4zpw2TTitjuRqUsSzB5DHlILaOG6qY1Tq2VpVGy6wUsWOWpsaA4spKzd6Sg6qu3DsS0hjIljrQedalMuZSZFqXgmqXaAvUDUiyG8fCeHhxzHJxUzRubiaLduwLGPuiGfuCB-TL_p1FC67xYO0TJM--JgJjNw_q5XXh5axQYCBqrg2FDiJwkIZuGOOM5BlwpYBmHu2IW3hpXRV3vBWQT_tikDN0nqjK1ZumDth2oPGzgIgOU3Qa1C2p5rMGsTtjknORBOTrjn3ufv7_Dr9_uK0fyHOKjIz4vPKIHKyXG_cRVkhr3W_EoE8O83w0GcH95PTi5yU8HfJhv9l1gOs4lf8AbosUpA |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwEB6VraC8IFhABAoYCZ4gamJnHecBoe3FlnZXqJf6ZuIj7Eptsuyhav8Uv5Fxjq22En3ra-wk9ngOj2c8H8BHRgOmXWjQhlHsR4YqPw1C62c2i5lIhUituzvcH_DeWfTjonOxBn-buzAurbLRiaWiNoV2Z-Rb1FWKSiLB2LfxH9-hRrnoagOhUbHFoV1co8s2_Xqwi-v7idL9vdOdnl-jCvia03jma-TRxCrNhFWpNjztZIHI0A3QWScwlmuaMqNUYEyaaSWSLA4sMzTSGpV5kimG330A6xFDV6YF69t7g5_Hy1MdFzeLwqS-nRMwsTVFC-lusaHPh9KDWomvWMASKGBld3s7N_NWgLa0e_tP4Um9YSXdisOewZrN2_CwgrBctGFj16UbOcS4Njzq14H65_C9mztYCvw0qTJGSJERbWeLy_FiMkJ7OZpfET106X_GklFOrhyU33U6HZIiJyfd4xN_pzj36Qs4uxfqvoRWXuT2FRAaIKNEFq2ssZEIuIgTpbKYKhsqg_zkQdjQUeq6oLnD1biUZWCdCVnRXiLtZUl7yT34vHxnXJXzuLP3tlueZU9Xirt8UEx-y1qyZYouqeJKU5ygK1WkcBpaWy14gnIQ4zA3m8WVtX6Yyhtu9uDDshkl24Vr0twW87IPepO4x0g8iFeYYmVAqy35aFjWCE-Y4DwOPfjSsM_Nz_8_4dd3j_U9bPRO-0fy6GBw-AYeU8fUrjqw2ITWbDK3b3F_NlPvaqEg8Ou-5fAfpR1QmQ |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGEIMXBAVExwAjwRNETew0dh4QKitlY2xCjE19M_HXWmlLSj809V_jr-MuH506ib3tNXYS-_y7O5_vfEfIW85CbtA16KJYBLFlOsjCyAXeecFlJmXm8O7w4VGydxJ_G3aHG-RvcxcGwyobmVgKalsYPCPvMMwUlcaS846vwyJ-9AefJn8CrCCFntamnEYFkQO3vATzbfZxvw9r_Y6xwZdfu3tBXWEgMAkT88AAXlOnDZdOZ8YmWdeH0oNJYHw3tC4xLONW69DazBstUy9Cxy2LjQHBnnrN4bt3yF3BuxHymBiK1fkOetDiKK3v6YRcdmagK_E-G1h_wEcgn5I1XViWDFjb516P0rzmqi014OAReVhvXWmvwtpjsuHyFrlXFbNctsj9PgYeYe24Ftk6rF32T8jXXo4FKuDTtIodoYWnxs2X55PldAyac7y4oGaEgYDW0XFOL7Co32U2G9Eip8e9n8fBbnEasKfk5FZo-4xs5kXunhPKQoBM7EDfWhfLMJEi1doLpl2kLSCrTaKGjsrUqc2xwsa5Kl3sXKqK9gpor0raq6RN3q_emVSJPW7s_RmXZ9UTk3KXD4rpmap5XGVgnOpEGwYTxKRFGqZhjDMySYEjBAxzp1lcVUuKmbrCdZu8WTUDj6PjJstdsSj7gF0Ju420TcQaKNYGtN6Sj0dltvCUyyQRUZt8aOBz9fP_T3j75rG-JlvAfer7_tHBC_KAIaYxTbDcIZvz6cK9hI3aXL8qOYKS37fNgv8AcUZTaQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antiviral+effect+of+cetylpyridinium+chloride+in+mouthwash+on+SARS-CoV-2&rft.jtitle=Scientific+reports&rft.au=Takeda%2C+Ryo&rft.au=Sawa%2C+Hirofumi&rft.au=Sasaki%2C+Michihito&rft.au=Orba%2C+Yasuko&rft.date=2022-08-18&rft.pub=Nature+Publishing+Group&rft.eissn=2045-2322&rft.volume=12&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-022-18367-6&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |